Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 116 pembrolizumab 112 Magnetic Resonance Spectroscopy 99 Carboplatin 83 Cyclophosphamide 70 Biopsy 63 Cisplatin 59 Paclitaxel 56 Bevacizumab 56 Gemcitabine 48 Nivolumab 45 fludarabine 39 Dexamethasone 37 atezolizumab 36 Rituximab 36 Pemetrexed 36 Fluorouracil 36 Docetaxel 35 Leucovorin 32 Doxorubicin 31 venetoclax 30 Radiotherapy 30 Oxaliplatin 29 Capecitabine 29 Temozolomide 27 Prednisone 26 Cetuximab 26 130-nm albumin-bound paclitaxel 25 Standard of Care 24 Letrozole 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Insulin × 30 days × Clear all

NCT05663515 2026-06-02

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡